Brenneman DE[au] - Search Results

Year	Number of Results
1972	2
1974	2
1975	2
1977	2
1979	1
1982	2
1983	3
1984	2
1985	3
1986	4
1987	3
1988	2
1989	4
1990	5
1991	7
1992	3
1993	7
1994	9
1995	5
1996	8
1997	11
1998	6
1999	13
2000	11
2001	8
2002	9
2003	10
2004	4
2005	6
2006	3
2007	6
2008	2
2009	2
2010	1
2012	1
2013	2
2014	2
2015	1
2016	1
2017	1
2018	1
2019	1
2021	1

1

Pharmacological Comparisons Between Cannabidiol and KLS-13019.

Brenneman DE, Petkanas D, Kinney WA. Brenneman DE, et al. J Mol Neurosci. 2018 Sep;66(1):121-134. doi: 10.1007/s12031-018-1154-7. Epub 2018 Aug 14. J Mol Neurosci. 2018. PMID: 30109468 Free PMC article.

2

Knockdown siRNA Targeting the Mitochondrial Sodium-Calcium Exchanger-1 Inhibits the Protective Effects of Two Cannabinoids Against Acute Paclitaxel Toxicity.

Brenneman DE, Kinney WA, Ward SJ. Brenneman DE, et al. J Mol Neurosci. 2019 Aug;68(4):603-619. doi: 10.1007/s12031-019-01321-z. Epub 2019 May 10. J Mol Neurosci. 2019. PMID: 31077084 Free PMC article.

3

Neuropeptides as growth and differentiation factors in general and VIP in particular.

Gozes I, Brenneman DE. Gozes I, et al. Among authors: brenneman de. J Mol Neurosci. 1993 Spring;4(1):1-9. doi: 10.1007/BF02736685. J Mol Neurosci. 1993. PMID: 8318354 Review.

4

VIP regulation of embryonic growth.

Hill JM, McCune SK, Alvero RJ, Glazner GW, Brenneman DE. Hill JM, et al. Among authors: brenneman de. Ann N Y Acad Sci. 1996 Dec 26;805:259-68; discussion 268-9. doi: 10.1111/j.1749-6632.1996.tb17488.x. Ann N Y Acad Sci. 1996. PMID: 8993408 Review.

5

PACAP functions as a neurotrophic factor.

Arimura A, Somogyvari-Vigh A, Weill C, Fiore RC, Tatsuno I, Bay V, Brenneman DE. Arimura A, et al. Among authors: brenneman de. Ann N Y Acad Sci. 1994 Oct 31;739:228-43. doi: 10.1111/j.1749-6632.1994.tb19825.x. Ann N Y Acad Sci. 1994. PMID: 7726997 Review. No abstract available.

6

VIP: molecular biology and neurobiological function.

Gozes I, Brenneman DE. Gozes I, et al. Among authors: brenneman de. Mol Neurobiol. 1989 Winter;3(4):201-36. doi: 10.1007/BF02740606. Mol Neurobiol. 1989. PMID: 2698176 Review.

7

A new concept in the pharmacology of neuroprotection.

Gozes I, Brenneman DE. Gozes I, et al. Among authors: brenneman de. J Mol Neurosci. 2000 Feb-Apr;14(1-2):61-8. doi: 10.1385/JMN:14:1-2:061. J Mol Neurosci. 2000. PMID: 10854037 Review.

8

Learning enhancement with neuropeptides.

Toso L, Endres M, Vink J, Abebe DT, Brenneman DE, Spong CY. Toso L, et al. Among authors: brenneman de. Am J Obstet Gynecol. 2006 Apr;194(4):1153-8; discussion 1158-9. doi: 10.1016/j.ajog.2005.12.023. Am J Obstet Gynecol. 2006. PMID: 16580319

9

Protective peptides derived from novel glial proteins.

Brenneman DE, Spong CY, Gozes I. Brenneman DE, et al. Biochem Soc Trans. 2000;28(4):452-5. Biochem Soc Trans. 2000. PMID: 10961938 Review.

10

Neuroprotection: a comparative view of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.

Brenneman DE. Brenneman DE. Peptides. 2007 Sep;28(9):1720-6. doi: 10.1016/j.peptides.2007.04.002. Epub 2007 Apr 19. Peptides. 2007. PMID: 17513014 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results